Dr. Kimberly Ann McBennett, MD

Dr. McBennett practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. McBennett's NPI, 1144205592, was assigned on December 8, 2005. Dr. McBennett graduated from Northeastern Ohio University College of Medicine in 2001. Dr. McBennett holds Ohio license 35-082661.

Dr. McBennett's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. McBennett's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. McBennett is also affiliated with University Hospitals Rainbow Babies & Children's Hospital. The medical group on file is University Hospitals Medical Practices.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McBennett practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatric pulmonology is Dr. McBennett's primary specialty in the NPI Registry, under taxonomy code 2080P0214X. Dr. McBennett is licensed in Ohio.

CMS data shows 50 Medicare services from Dr. McBennett across 2 procedure codes in 2021, for 23 Medicare patients. Medicare paid $3,537 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 23 Medicare patients who saw Dr. McBennett in 2024. 61% of them have anxiety, and 61% have high blood pressure. Their average risk score is 3.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McBennett's median patient age at 28, with 60% women.

In 2024, Dr. McBennett wrote 1,329 Medicare Part D claims for 36 patients. 52% of them were for generic drugs. CMS names the drug for 975 of them, across 34 drugs with 11 or more claims each, at $6,732,662 in total drug cost. In 2023, CMS named 1,258 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. McBennett for performance year 2024, reported as part of a group. Dr. McBennett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McBennett as offering telehealth.

Dmand AI links 11 papers to Dr. McBennett, published from 2013 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator and Aminophenols. Dr. McBennett has published most often in Pediatr Pulmonol. Dr. McBennett's most frequent co-authors are Katherine A. Kutney, MD, Pamela B. Davis, MD and Michael W. Konstan, MD.

Dmand AI links Dr. McBennett to 1 clinical trial. Conditions studied include Cystic Fibrosis and Infant, Newborn, Diseases.

CMS Open Payments shows 45 general payments to Dr. McBennett from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Vertex Pharmaceuticals Incorporated paid the most, $7,278.

Dr. McBennett graduated from Northeastern Ohio University College of Medicine in 2001.